Nurix Therapeutics, Inc. NRIX Investing Cash Flow
Investing Cash Flow at other companies
Other financials
Where this comes from
Reported directly by Nurix Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:NetCashProvidedByUsedInInvestingActivities.
The official record: Nurix Therapeutics, Inc.’s 10-Q, filed April 8, 2026, on SEC EDGAR. View the filing →
Ask your AI about Nurix Therapeutics, Inc.'s investing cash flow.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Nurix Therapeutics, Inc.'s investing cash flow?
- Nurix Therapeutics, Inc. (NRIX) reported investing cash flow of -$123.83M in Q4 2025.
- How has Nurix Therapeutics, Inc.'s investing cash flow changed year-over-year?
- Nurix Therapeutics, Inc.'s investing cash flow decreased by 585.0% year-over-year, from $25.53M to -$123.83M.
- What is the long-term trend for Nurix Therapeutics, Inc.'s investing cash flow?
- Over 2 years (2021 to 2025), Nurix Therapeutics, Inc.'s investing cash flow has grown at a 16.9% compound annual growth rate (CAGR), from -$108.25M to $147.85M.
- What does investing cash flow mean?
- Total net cash provided by or used in investing activities — capex, acquisitions, investment purchases/sales, and other investing items.